Randomized comparison of daclatasvir + asunaprevir versus telaprevir + peginterferon/ribavirin in Japanese HCV patients

ConclusionMarked differences were observed in the efficacy and safety profile of daclatasvir in combination with asunaprevir, compared with telaprevir plus peginterferon/ribavirin. This article is protected by copyright. All rights reserved.

Source: Journal of Gastroenterology and Hepatology - August 7, 2015 Category: Gastroenterology Authors: Hiromitsu Kumada, Fumitaka Suzuki, Yoshiyuki Suzuki, Joji Toyota, Yoshiyasu Karino, Kazuaki Chayama, Yoshiiku Kawakami, Shigetoshi Fujiyama, Takayoshi Ito, Yoshito Itoh, Etsuko Tamura, Tomoko Ueki, Hiroki Ishikawa, Wenhua Hu, Fiona McPhee, Misti Linaberry Tags: Clinical Trials and Therapeutics Source Type: research